Improving the effectiveness of psychological interventions for depression and anxiety in the cardiac rehabilitation pathway: a single-blind randomised controlled trial

Conditions

Topic: Cardiovascular disease

Gemma Shields, Elizabeth Camacho, Linda Davies, Patrick Doherty, David Reeves et al. (10 authors)

BMJ Open2024-12-012 citations

10.1136/bmjopen-2024-087414

Improving the Effectiveness of Psychological Interventions for Depression and Anxiety in Cardiac Rehabilitation: The PATHWAY Research Programme Including 4 RCTs

Adrian Wells, David Reeves, Peter Fisher, Linda Davies, Gemma Shields et al. (10 authors)

Programme Grants for Applied Research2024-09-011 citations

10.3310/tmja2644

Evaluating Metacognitive Therapy to Improve Treatment of Anxiety and Depression in Cardiovascular Disease: The NIHR Funded PATHWAY Research Programme.

Wells A, Reeves D, Heal C, Davies LM, Shields GE, Heagerty A, Fisher P, Doherty P, Capobianco L.

2022-06-0311 citations

10.3389/fpsyt.2022.886407

Improving the Effectiveness of Psychological Interventions for Depression and Anxiety in Cardiac Rehabilitation: PATHWAY—A Single-Blind, Parallel, Randomized, Controlled Trial of Group Metacognitive Therapy

Adrian Wells, David Reeves, Lora Capobianco, Calvin Heal, Linda Davies et al. (8 authors)

Circulation2021-06-2187 citations

10.1161/circulationaha.120.052428

Protocol for the economic evaluation of metacognitive therapy for cardiac rehabilitation participants with symptoms of anxiety and/or depression

Gemma Shields, Adrian Wells, Patrick Doherty, David Reeves, Lora Capobianco et al. (8 authors)

BMJ Open2020-09-015 citations

10.1136/bmjopen-2019-035552

Improving the effectiveness of psychological interventions for depression and anxiety in the cardiac rehabilitation pathway using group-based metacognitive therapy (PATHWAY Group MCT): study protocol for a randomised controlled trial.

Wells A, McNicol K, Reeves D, Salmon P, Davies L, Heagerty A, Doherty P, McPhillips R, Anderson R, Faija C, Capobianco L, Morley H, Gaffney H, Shields G, Fisher P.

2018-04-0331 citations

10.1186/s13063-018-2593-8

Interventions

1. Experimental: metacognitive therapy plus CR Group psychological treatment focused on reducing worry and rumination and modifying beliefs about thinking in addition to treatment as usual (standard c

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Heart disease patients referred to CR who meet DoH and/or BACPR CR eligibility criteria 2. Minimum of 18 years old 3. Competent level of English language skills (able to read, understand and complete questionnaires in English). 4. Acute coronary syndrome used for any condition brought on by sudden, reduced blood flow to the heart 5. Following revascularisation is the restoration of perfusion to a body part or organ that has suffered ischemia 6. Stable heart failure 7. Stable angina is chest pain or discomfort that most often occurs with activity or stress 8. Following implantation of cardioverter defibrillators/cardiac resynchronisation devices 9. Heart valve repair/replacement 10. Heart transplantation and ventricular assist devices 11. Adult congenital heart disease identified in adulthood 12. A score of = 8 on either the depression or anxiety subscale of the HADS.

Exclusion criteria

Exclusion criteria: 1. Cognitive impairment which precludes informed consent or ability to participate 2. Acute suicidality 3. Active psychotic disorders (i.e., two [or more] of the following: delusions, hallucinations, disorganized speech, grossly disorganized or catatonic behaviour, negative symptoms) 4. Current drug/alcohol abuse a maladaptive pattern of drinking, leading to clinically significant impairment or distress 5. Concurrent psychological intervention for emotional distress 6. Antidepressant or anxiolytic medications initiated in the previous 8 weeks 7. Life expectancy of less than 12 months

Design outcomes

Primary

Measure	Time frame
Change in Hospital Anxiety and Depression Scale (HADS) [Time Frame: Baseline pre treatment, four-month post baseline, 12 months follow-up]	—

Secondary

Measure	Time frame
1. Metacognitions Questionnaire 2. Cognitive Attentional Syndrome 3. Impact of Event Scale-Revised 4. Health Related Quality of Life 5. Economic Patient Questionnaire (EPQ)	—

Countries

England, United Kingdom

Outcome results

None listed